[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-001", "question": "A 68-year-old man with a history of severe aortic stenosis (mean gradient 48 mmHg, AVA 0.7 cm²) presents with decompensated heart failure. He is hypotensive (85/50 mmHg) and hypoxic despite high-flow oxygen. Transthoracic echocardiography shows a hyperdynamic left ventricle with near-cavity obliteration, severe mitral regurgitation (new, eccentric posteriorly directed jet), and systolic anterior motion of the mitral valve with LVOT obstruction (peak gradient 120 mmHg). Which of the following is the single most appropriate immediate pharmacologic intervention?", "options": ["Intravenous phenylephrine infusion", "Intravenous esmolol infusion", "Intravenous nitroglycerin infusion", "Intravenous furosemide bolus", "Intravenous milrinone infusion"], "answer": "A", "answer_index": 0, "explanation": "This patient has severe aortic stenosis with a dynamic LVOT obstruction (systolic anterior motion) precipitated by hypovolemia and hypercontractility, leading to hypotension and secondary mitral regurgitation. Phenylephrine, an alpha-agonist, increases afterload and blood pressure, which reduces the LVOT gradient and improves forward flow. Esmolol (negative inotrope) could worsen heart failure in the setting of severe AS. Nitroglycerin and furosemide reduce preload, exacerbating the obstruction. Milrinone is a positive inotrope and vasodilator, which would dramatically worsen the LVOT gradient and hypotension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Let me analyze this case carefully.\n\nThis patient has severe aortic stenosis but is presenting with a complex hemodynamic picture:\n- Hyperdynamic LV with near-cavity obliteration\n- NEW eccentric posteriorly directed MR jet\n- Systolic anterior motion (SAM) of the mitral valve\n- LVOT obstruction with peak gradient of 120 mmHg\n- Hypotension (85/50 mmHg)\n\nThis presentation is consistent with dynamic LVOT obstruction, likely triggered by hypovolemia or excessive preload reduction in the setting of severe AS. The SAM is causing both the LVOT obstruction and the mitral regurgitation (the posteriorly directed jet is classic for SAM-related MR).\n\nThe pathophysiology here is:\n- Hyperdynamic state → cavity obliteration → SAM → LVOT obstruction → worsening hypotension → further sympathetic activation → worsening obstruction (vicious cycle)\n\nTreatment goals for dynamic LVOT obstruction with SAM:\n1. Increase afterload (to reduce the Venturi effect pulling the mitral leaflet into the LVOT)\n2. Decrease contractility\n3. Increase preload\n4. Slow heart rate\n\nLet me evaluate the options:\n\nA. Phenylephrine - Pure alpha-agonist, increases afterload without increasing contractility. This would help reduce the LVOT gradient by increasing afterload and potentially improving coronary perfusion.\n\nB. Esmolol - Beta-blocker would decrease contractility and heart rate, which would help reduce the dynamic obstruction. However, in a hypotensive patient, this could worsen hypotension.\n\nC. Nitroglycerin - Vasodilator would WORSEN the situation by reducing preload and afterload, exacerbating the dynamic obstruction. Contraindicated.\n\nD. Furosemide - Diuretic would reduce preload, worsening the dynamic obstruction. Contraindicated.\n\nE. Milrinone - Inotrope and vasodilator would increase contractility and reduce afterload, dramatically worsening the dynamic obstruction. Contraindicated.\n\nBetween phenylephrine and esmolol, in a hypotensive patient with dynamic LVOT obstruction, phenylephrine is the most appropriate immediate intervention. It will increase afterload, which helps reduce the Venturi effect causing SAM, and will support blood pressure. While esmolol could help with the hyperdynamic state, giving a beta-blocker to someone with BP 85/50 is risky without first supporting the blood pressure.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-002", "question": "A 3-day-old full-term neonate, born via uncomplicated vaginal delivery, is noted to have progressive tachypnea, grunting, and hypoxemia requiring 60% FiO2. Chest X-ray shows diffuse granular opacities with air bronchograms. Surfactant administration provides minimal improvement. Echocardiogram shows normal cardiac anatomy, but there is severe pulmonary hypertension with suprasystemic right ventricular pressures and right-to-left shunting across a patent foramen ovale. Which of the following underlying conditions is the most likely cause of this refractory pulmonary hypertension of the newborn?", "options": ["Congenital alveolar capillary dysplasia", "Meconium aspiration syndrome", "Transient tachypnea of the newborn", "Group B streptococcal pneumonia", "Idiopathic respiratory distress syndrome"], "answer": "A", "answer_index": 0, "explanation": "Congenital alveolar capillary dysplasia (ACD) with misalignment of pulmonary veins is a rare, lethal lung developmental disorder that presents identically to severe persistent pulmonary hypertension of the newborn (PPHN) but is completely refractory to all standard therapies, including surfactant, inhaled nitric oxide, and ECMO. The history of a full-term infant with rapid progression and lack of response to surfactant is classic. Meconium aspiration and sepsis can cause severe PPHN but typically show some response to aggressive management. Transient tachypnea and idiopathic RDS are not associated with such severe, immediate refractory pulmonary hypertension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Let me analyze this case systematically.\n\nKey clinical features:\n- 3-day-old full-term neonate\n- Born via uncomplicated vaginal delivery\n- Progressive tachypnea, grunting, hypoxemia requiring 60% FiO2\n- CXR: diffuse granular opacities with air bronchograms\n- Surfactant administration provided minimal improvement\n- Echo: normal cardiac anatomy\n- Severe pulmonary hypertension with suprasystemic RV pressures\n- Right-to-left shunting across PFO\n- Refractory to treatment\n\nAnalyzing each option:\n\nA. Congenital alveolar capillary dysplasia (ACD)\n- Rare, fatal condition with abnormal pulmonary vascular development\n- Presents with severe, refractory PPHN in term newborns\n- Characteristically does NOT respond to conventional treatments (surfactant, iNO, ECMO)\n- CXR can show diffuse opacities\n- Key feature: refractory pulmonary hypertension\n\nB. Meconium aspiration syndrome\n- Usually associated with meconium-stained amniotic fluid\n- Question states \"uncomplicated vaginal delivery\"\n- Can cause PPHN but typically responds to treatment\n\nC. Transient tachypnea of the newborn\n- Self-limiting condition\n- Resolves within 24-72 hours\n- Does not cause severe refractory PPHN\n\nD. Group B streptococcal pneumonia\n- Can cause PPHN\n- Usually presents earlier (within first 24-48 hours)\n- Would typically respond to antibiotics and supportive care\n- Not typically \"refractory\"\n\nE. Idiopathic respiratory distress syndrome\n- More common in preterm infants\n- This is a full-term baby\n- Usually responds to surfactant\n\nCritical reasoning:\nThe key distinguishing feature here is that this is a full-term infant with refractory pulmonary hypertension that does not respond to surfactant. The combination of:\n1. Full-term neonate\n2. Severe PPHN with suprasystemic pressures\n3. Minimal response to surfactant\n4. Refractory nature of the condition\n\nThis presentation is classic for Congenital Alveolar Capillary Dysplasia, which is characterized by maldevelopment of pulmonary capillaries leading to severe, treatment-resistant pulmonary hypertension.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-003", "question": "A 42-year-old woman is brought to the ED after a high-speed motor vehicle collision. Primary survey reveals a Glasgow Coma Scale of 14, heart rate 130 bpm, BP 88/50 mmHg, and SpO2 94% on room air. Focused Assessment with Sonography for Trauma (FAST) is positive for fluid in the hepatorenal recess. After initiating a massive transfusion protocol, her blood pressure transiently improves with crystalloid, then drops again. Bedside ultrasound now shows a new, large pericardial effusion with diastolic right ventricular collapse. Which of the following is the most appropriate immediate procedural intervention?", "options": ["Emergency department thoracotomy", "Pericardiocentesis via subxiphoid approach", "Left anterolateral tube thoracostomy", "Right tube thoracostomy", "Laparotomy with aortic cross-clamping"], "answer": "B", "answer_index": 1, "explanation": "The patient has developed cardiac tamponade (evidenced by diastolic RV collapse on ultrasound) in the context of trauma and a positive FAST exam, suggesting concurrent intra-abdominal hemorrhage. In blunt trauma, the cause is likely myocardial rupture or coronary vessel injury. Pericardiocentesis is the immediate life-saving procedure to relieve tamponade while simultaneously preparing for definitive operative management. ED thoracotomy is indicated for penetrating trauma with recent loss of signs of life. Tube thoracostomy addresses hemothorax, not pericardial tamponade. Laparotomy addresses the abdominal hemorrhage but would not relieve the cardiac tamponade, and the patient would likely arrest on induction of anesthesia.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nClinical Presentation:\n- 42-year-old woman after high-speed MVC\n- Hemodynamically unstable: HR 130, BP 88/50 (shock)\n- Initial FAST positive for fluid in hepatorenal recess (suggesting intra-abdominal hemorrhage)\n- Transient response to crystalloid (suggests ongoing hemorrhage)\n- NEW finding: Large pericardial effusion with diastolic RV collapse\n\nKey Finding Analysis:\nThe new pericardial effusion with diastolic RV collapse indicates cardiac tamponade. This is causing obstructive shock and is immediately life-threatening. The RV diastolic collapse is a classic echocardiographic sign of tamponade physiology.\n\nEvaluating Options:\n\nA. Emergency department thoracotomy - This is indicated for penetrating trauma with witnessed cardiac arrest or patients in extremis who are about to arrest. While this patient is unstable, she still has a BP and is not in cardiac arrest.\n\nB. Pericardiocentesis via subxiphoid approach - This is the standard immediate intervention for cardiac tamponade. It can be performed quickly at bedside, is less invasive than thoracotomy, and can be life-saving by removing even small amounts of pericardial fluid to relieve tamponade.\n\nC. Left anterolateral tube thoracostomy - This addresses hemothorax/pneumothorax, not pericardial effusion.\n\nD. Right tube thoracostomy - Same as above, addresses pleural space issues, not pericardial.\n\nE. Laparotomy with aortic cross-clamping - While she has intra-abdominal fluid, the immediate life threat is the cardiac tamponade causing obstructive shock. This needs to be addressed first.\n\nDecision:\nIn blunt trauma with cardiac tamponade, pericardiocentesis is the appropriate first-line intervention. It's rapid, can be done at bedside under ultrasound guidance, and can stabilize the patient. ED thoracotomy is typically reserved for penetrating trauma or imminent/actual cardiac arrest. Since this patient has a blood pressure and is not arresting, pericardiocentesis is the most appropriate immediate intervention.\n\nThe answer is (B)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-004", "question": "A 28-year-old woman presents with a 6-month history of symmetric inflammatory polyarthritis affecting her wrists, MCPs, and knees, morning stiffness >1 hour, and a new facial rash. Labs show ANA 1:1280 (speckled), anti-dsDNA negative, anti-Smith positive, anti-RNP positive, complement levels normal, and urinalysis with 2+ protein but no cellular casts. She is started on hydroxychloroquine. Two weeks later, she develops acute dyspnea, pleuritic chest pain, and hypoxia. CT pulmonary angiography shows no pulmonary embolism but reveals extensive bilateral ground-glass opacities and pleural effusions. Which of the following is the most likely diagnosis?", "options": ["Lupus pneumonitis", "Drug reaction to hydroxychloroquine", "Acute pulmonary hemorrhage from vasculitis", "Pulmonary hypertension due to SLE", "Opportunistic infection due to immunosuppression"], "answer": "A", "answer_index": 0, "explanation": "The patient has SLE (meeting criteria with arthritis, malar rash, anti-Smith positivity). The acute respiratory presentation with ground-glass opacities and pleural effusions in this context is most consistent with acute lupus pneumonitis, a rare but severe manifestation of SLE. Timing makes drug reaction unlikely, as hydroxychloroquine toxicity is typically chronic and not acute pulmonary. Pulmonary hemorrhage would show falling hematocrit and more alveolar filling. Pulmonary hypertension is a chronic process. Opportunistic infection is improbable given the very short course of a minimally immunosuppressive agent (hydroxychloroquine).", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Let me analyze this case systematically.\n\nPatient Profile:\n- 28-year-old woman with 6-month history of:\n  - Symmetric inflammatory polyarthritis (wrists, MCPs, knees)\n  - Morning stiffness >1 hour\n  - Facial rash\n  - ANA 1:1280 (speckled), anti-Smith positive, anti-RNP positive\n  - Anti-dsDNA negative, normal complement\n  - Proteinuria (2+) without cellular casts\n\nThis presentation is consistent with Systemic Lupus Erythematosus (SLE) - she meets criteria with arthritis, facial rash, positive ANA, anti-Smith antibody (highly specific for SLE), and renal involvement.\n\nAcute Presentation (2 weeks after starting hydroxychloroquine):\n- Acute dyspnea, pleuritic chest pain, hypoxia\n- CT: bilateral ground-glass opacities and pleural effusions\n- No pulmonary embolism\n\nAnalyzing Options:\n\nA. Lupus pneumonitis: Acute lupus pneumonitis presents with fever, dyspnea, pleuritic pain, hypoxia, and bilateral infiltrates/ground-glass opacities. Pleural effusions are common in SLE. This is a known pulmonary manifestation of active SLE.\n\nB. Drug reaction to hydroxychloroquine: Hydroxychloroquine rarely causes acute pulmonary toxicity. It's generally well-tolerated and is actually used to treat SLE. Pulmonary toxicity from HCQ is extremely rare and typically occurs with long-term use, not 2 weeks.\n\nC. Acute pulmonary hemorrhage from vasculitis: This would typically present with hemoptysis and would show diffuse alveolar hemorrhage pattern. No mention of hemoptysis or bloody secretions.\n\nD. Pulmonary hypertension due to SLE: This develops gradually, not acutely over 2 weeks. Would not explain ground-glass opacities and pleural effusions in this pattern.\n\nE. Opportunistic infection: Hydroxychloroquine is not significantly immunosuppressive. She hasn't been on steroids or other immunosuppressants. This is unlikely after only 2 weeks of a mild immunomodulator.\n\nConclusion: The most likely diagnosis is Lupus pneumonitis - an acute pulmonary manifestation of SLE presenting with the classic triad of dyspnea, pleuritic chest pain, and bilateral infiltrates with pleural effusions in a patient with active SLE.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-005", "question": "A 55-year-old man with a history of MEN1 syndrome (previous parathyroidectomy, pancreatic neuroendocrine tumor resection) presents with profound hypoglycemia (glucose 38 mg/dL) and inappropriately elevated serum insulin and C-peptide during a supervised fast. Localizing studies, including endoscopic ultrasound and Ga-68 DOTATATE PET/CT, show no identifiable pancreatic lesion. Which of the following is the most appropriate next step in management?", "options": ["Empiric distal pancreatectomy", "Initiation of diazoxide therapy", "Selective arterial calcium stimulation with hepatic venous sampling", "Empiric total pancreatectomy", "Long-acting somatostatin analog therapy (e.g., lanreotide)"], "answer": "C", "answer_index": 2, "explanation": "In a patient with MEN1 and biochemically proven endogenous hyperinsulinemic hypoglycemia (insulinoma) with negative conventional and advanced imaging, the next step is selective arterial calcium stimulation (SACS) with hepatic venous sampling. This invasive angiographic procedure can regionalize the source of insulin secretion to a specific pancreatic arterial territory (gastroduodenal, superior mesenteric, or splenic arteries), guiding targeted surgical exploration. Empiric distal or total pancreatectomy carries high morbidity and may miss the lesion. Diazoxide and somatostatin analogs are temporizing medical therapies but do not address the need for definitive localization and resection in a surgical candidate.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n- 55-year-old man with MEN1 syndrome\n- History of parathyroidectomy and pancreatic neuroendocrine tumor resection\n- Profound hypoglycemia (38 mg/dL)\n- Elevated insulin and C-peptide during supervised fast (confirms endogenous hyperinsulinism)\n- Negative localization studies (EUS and Ga-68 DOTATATE PET/CT show no lesion)\n\nDiagnosis: This is biochemically confirmed insulinoma (Whipple's triad with inappropriate hyperinsulinemia and elevated C-peptide).\n\nThe Challenge: The tumor cannot be localized with standard imaging.\n\nEvaluating Options:\n\nA. Empiric distal pancreatectomy - Without localization, this is a blind approach. Insulinomas can occur anywhere in the pancreas, and empiric surgery without knowing tumor location has significant morbidity and may miss the lesion.\n\nB. Diazoxide therapy - This is medical management that can help control hypoglycemia but doesn't address the underlying tumor. It's typically used as a bridge or for patients who are not surgical candidates.\n\nC. Selective arterial calcium stimulation with hepatic venous sampling (SACSHVS) - This is the gold standard for localizing occult insulinomas when non-invasive imaging fails. Calcium stimulates insulin release from insulinoma cells, and sampling from hepatic veins can regionalize the tumor to specific pancreatic arterial territories (gastroduodenal, splenic, superior mesenteric arteries).\n\nD. Empiric total pancreatectomy - This is overly aggressive and would result in diabetes and exocrine insufficiency. Not appropriate without attempting localization.\n\nE. Long-acting somatostatin analog therapy - While somatostatin analogs can help some insulinomas, they may paradoxically worsen hypoglycemia in some cases by suppressing glucagon more than insulin. This is also medical management, not definitive.\n\nBest Answer: Given that this patient has biochemically confirmed insulinoma but negative standard imaging, the most appropriate next step is selective arterial calcium stimulation with hepatic venous sampling to localize the tumor before surgical intervention. This is the established approach for occult insulinomas.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-006", "question": "A 7-year-old boy is evaluated for short stature. He has a history of congenital hypothyroidism diagnosed on newborn screening, treated with levothyroxine. Growth chart shows length and weight at the 5th percentile at birth, falling to below the 1st percentile by age 3. Current bone age is delayed by 3 years. Physical exam reveals a prominent forehead, depressed nasal bridge, and small hands with brachydactyly. Labs show normal TSH and free T4 on replacement. Which of the following genetic mutations is most likely responsible for this clinical picture?", "options": ["SHOX gene mutation", "GH1 gene mutation (isolated GH deficiency)", "GNAS1 gene mutation (Albright hereditary osteodystrophy)", "PROP1 gene mutation (combined pituitary hormone deficiency)", "FGFR3 gene mutation (achondroplasia)"], "answer": "D", "answer_index": 3, "explanation": "The combination of congenital hypothyroidism, severe postnatal growth failure with delayed bone age, and mild facial dysmorphism is classic for combined pituitary hormone deficiency (CPHD) due to a PROP1 mutation. PROP1 is a pituitary transcription factor critical for the development of somatotrophs, lactotrophs, thyrotrophs, and gonadotrophs. Deficiency presents with growth hormone, TSH, and later gonadotropin deficiencies. The congenital hypothyroidism was central (pituitary), not primary thyroidal. SHOX mutations cause Leri-Weill dyschondrosteosis. GNAS1 mutations cause pseudohypoparathyroidism with specific skeletal findings (brachydactyly type E). Isolated GH deficiency or achondroplasia would not explain the central hypothyroidism.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nKey clinical features:\n- 7-year-old boy with short stature\n- Congenital hypothyroidism (diagnosed on newborn screening)\n- Growth: 5th percentile at birth, fell to <1st percentile by age 3\n- Bone age delayed by 3 years\n- Physical features: prominent forehead, depressed nasal bridge, small hands with brachydactyly\n- Normal TSH and free T4 on levothyroxine replacement\n\nAnalysis of options:\n\nA. SHOX gene mutation: Causes Leri-Weill dyschondrosteosis or short stature. Features include Madelung deformity, mesomelia. Not typically associated with congenital hypothyroidism or the described facial features.\n\nB. GH1 gene mutation: Isolated GH deficiency would cause short stature and delayed bone age, but wouldn't explain congenital hypothyroidism or the specific dysmorphic features described.\n\nC. GNAS1 gene mutation (Albright hereditary osteodystrophy/Pseudohypoparathyroidism): Features include short stature, brachydactyly (especially 4th and 5th metacarpals), round face, and importantly can cause resistance to multiple hormones including TSH (leading to hypothyroidism), PTH, and others. The combination of congenital hypothyroidism + short stature + brachydactyly + characteristic facial features fits well.\n\nD. PROP1 gene mutation: Causes combined pituitary hormone deficiency affecting GH, TSH, LH/FSH, and sometimes ACTH. However, this typically presents with central hypothyroidism (low TSH), not the pattern seen in congenital hypothyroidism detected on newborn screening (which typically detects primary hypothyroidism with elevated TSH).\n\nE. FGFR3 gene mutation (achondroplasia): Causes rhizomelic short stature with characteristic features including frontal bossing and depressed nasal bridge. However, achondroplasia is not associated with hypothyroidism, and brachydactyly is not a typical feature.\n\nBest fit: The combination of congenital hypothyroidism (TSH resistance), short stature, brachydactyly, and facial features strongly suggests Albright hereditary osteodystrophy caused by GNAS1 mutation. This condition causes hormone resistance at the receptor level, explaining the hypothyroidism that would be detected on newborn screening.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-007", "question": "A 70-year-old man with severe, calcific aortic stenosis (AVA 0.6 cm², mean gradient 55 mmHg) and chronic kidney disease (eGFR 28 mL/min/1.73m²) presents with recurrent hospitalizations for heart failure with preserved ejection fraction (LVEF 65%). He is deemed high-risk for surgical AVR. He undergoes transcatheter aortic valve implantation (TAVI) with a balloon-expandable valve. Immediately post-deployment, transesophageal echocardiography shows a well-seated valve with mild paravalvular leak, mean gradient 8 mmHg, and new severe mitral regurgitation with a wide vena contracta and eccentric anteriorly directed jet. The left ventricular systolic function appears hyperdynamic. What is the most likely mechanism of the acute severe mitral regurgitation?", "options": ["Iatrogenic injury to the mitral valve apparatus from the delivery system", "Dynamic left ventricular outflow tract obstruction causing systolic anterior motion of the mitral valve", "Unmasking of pre-existing severe ischemic mitral regurgitation due to afterload reduction", "Valve prosthesis impingement on the anterior mitral leaflet", "Acute papillary muscle dysfunction due to coronary occlusion"], "answer": "B", "answer_index": 1, "explanation": "In a patient with severe AS and a small, hypertrophied, hyperdynamic left ventricle, relief of the afterload obstruction via TAVI can precipitate dynamic LVOT obstruction. This leads to systolic anterior motion (SAM) of the mitral valve, causing acute, severe mitral regurgitation with an eccentric anterior jet. This is a recognized complication of TAVI, particularly in patients with certain anatomical predictors (septal hypertrophy, small LV cavity). Direct injury from the delivery system is rare. Pre-existing severe MR would have been evident pre-procedure. Prosthetic impingement typically causes central MR. Coronary occlusion is possible but would more likely cause regional wall motion abnormalities and ischemic MR.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "Let me analyze this case systematically.\n\nKey findings:\n- Post-TAVI with balloon-expandable valve\n- New severe mitral regurgitation (MR)\n- Wide vena contracta, eccentric anteriorly directed jet\n- Hyperdynamic LV function\n- LVEF was preserved (65%) pre-procedure\n- Mean gradient dropped from 55 mmHg to 8 mmHg (significant afterload reduction)\n\nLet me evaluate each option:\n\nA. Iatrogenic injury to mitral valve apparatus - This is possible but would typically cause a central jet or posterior-directed jet if the anterior leaflet is damaged.\n\nB. Dynamic LVOT obstruction with SAM - This fits well. After TAVI, there's sudden afterload reduction. In patients with preserved/hyperdynamic LV function, this can unmask or cause systolic anterior motion (SAM) of the mitral valve. SAM causes an anteriorly directed eccentric MR jet (toward the posterior left atrium, but the jet direction described as \"anteriorly directed\" in echo terminology typically means the leaflet pathology is posterior - however, SAM specifically causes a posteriorly-directed jet into the LA). Wait - let me reconsider. An anteriorly directed jet suggests posterior leaflet pathology or SAM pulling the anterior leaflet forward, creating a gap posteriorly... Actually, SAM typically causes a posterolaterally directed jet.\n\nC. Unmasking pre-existing ischemic MR - Ischemic MR typically causes a centrally or posteriorly directed jet due to restricted posterior leaflet motion.\n\nD. Valve prosthesis impingement on anterior mitral leaflet - This is a known complication of TAVI, especially with balloon-expandable valves. The prosthesis can be positioned too deep and impinge on the anterior mitral leaflet, restricting its motion and causing MR. This would cause an anteriorly directed jet (toward the aorta/anterior LA wall) because the anterior leaflet cannot coapt properly.\n\nE. Acute papillary muscle dysfunction from coronary occlusion - This would typically cause a posteriorly directed jet and would show wall motion abnormalities, not hyperdynamic function.\n\nThe key clues are:\n1. Anteriorly directed eccentric jet - suggests anterior leaflet dysfunction\n2. Hyperdynamic LV - could support SAM or simply reflect the patient's baseline\n3. Immediate post-deployment timing\n\nProsthesis impingement on the anterior mitral leaflet (option D) is a recognized complication of TAVI, particularly when the valve is deployed too deep. This restricts anterior leaflet motion, preventing proper coaptation, and results in an anteriorly directed MR jet.\n\nThe answer is (D)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-008", "question": "A 4-week-old male infant is admitted with a 2-day history of poor feeding, lethargy, and vomiting. He was born at term, breastfeeding well until this illness. Vital signs: T 36.8°C, HR 180 bpm, RR 65/min, BP 65/40 mmHg, SpO2 98% room air. He is mottled, with delayed capillary refill. Laboratory studies show: Na 125 mEq/L, K 8.9 mEq/L, Cl 94 mEq/L, CO2 14 mEq/L, glucose 48 mg/dL, Ca 9.8 mg/dL. Point-of-care cortisol is 2 mcg/dL (drawn prior to any steroid administration). Which of the following is the most urgent diagnostic test to confirm the underlying etiology?", "options": ["Plasma renin activity and aldosterone level", "Karyotype analysis", "Serum 17-hydroxyprogesterone level", "ACTH stimulation test", "Urine organic acid analysis"], "answer": "C", "answer_index": 2, "explanation": "The infant presents in acute adrenal crisis with profound hyponatremia, hyperkalemia, hypoglycemia, and low cortisol, diagnostic of primary adrenal insufficiency. The most common cause in a male infant is congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is detected by a markedly elevated serum 17-hydroxyprogesterone level. This is the most urgent specific diagnostic test, as it guides definitive management and genetic counseling. Plasma renin activity will be elevated, but does not specify the etiology. Karyotype is not urgent; males with CAH have a 46,XY karyotype. An ACTH stimulation test is diagnostic for adrenal insufficiency but is contraindicated in acute crisis and does not identify the specific enzyme defect. Urine organic acids help diagnose other metabolic disorders.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nClinical Presentation:\n- 4-week-old male infant\n- Poor feeding, lethargy, vomiting for 2 days\n- Signs of shock: tachycardia (HR 180), tachypnea (RR 65), hypotension (65/40), mottled skin, delayed capillary refill\n\nLaboratory Findings:\n- Hyponatremia: Na 125 mEq/L\n- Severe hyperkalemia: K 8.9 mEq/L\n- Metabolic acidosis: CO2 14 mEq/L\n- Hypoglycemia: glucose 48 mg/dL\n- Low cortisol: 2 mcg/dL\n\nDiagnosis:\nThis presentation is classic for Congenital Adrenal Hyperplasia (CAH) with salt-wasting crisis, most commonly due to 21-hydroxylase deficiency. The combination of:\n- Adrenal crisis in a male infant at 2-4 weeks of age\n- Hyponatremia with hyperkalemia (mineralocorticoid deficiency)\n- Hypoglycemia and low cortisol (glucocorticoid deficiency)\n- Metabolic acidosis\n\nEvaluating the Options:\n\nA. Plasma renin activity and aldosterone level - Would show high renin and low aldosterone, but this is supportive, not confirmatory of the specific etiology.\n\nB. Karyotype analysis - Important if there's ambiguous genitalia to determine genetic sex, but not the most urgent diagnostic test for confirming CAH.\n\nC. Serum 17-hydroxyprogesterone level - This is the definitive diagnostic test for 21-hydroxylase deficiency (the most common cause of CAH, ~95% of cases). It will be markedly elevated and confirms the diagnosis.\n\nD. ACTH stimulation test - Used to assess adrenal reserve, but in this acute setting with clear adrenal insufficiency and suspected CAH, 17-OHP is more specific and urgent.\n\nE. Urine organic acid analysis - Used for metabolic disorders, not relevant here.\n\nThe most urgent diagnostic test to confirm the underlying etiology (21-hydroxylase deficiency CAH) is serum 17-hydroxyprogesterone level.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-009", "question": "A 32-year-old woman with a history of systemic sclerosis (limited cutaneous variant, anti-centromere positive) presents to the rheumatology clinic for routine follow-up. She reports excellent control of her Raynaud's phenomenon and stable skin disease. She has no cardiac or renal symptoms. Her vital signs are normal. A screening transthoracic echocardiogram is performed, which reveals normal left and right ventricular size and function, but there is a small to moderate pericardial effusion. Which of the following findings on echocardiogram would be the strongest indicator to initiate specific pharmacologic therapy directed at the effusion?", "options": ["Right atrial diastolic collapse", "Respiratory variation in mitral inflow velocity >25%", "Inferior vena cava plethora with <50% collapse on sniff", "Swinging heart motion", "Left atrial compression during systole"], "answer": "C", "answer_index": 2, "explanation": "In a patient with a chronic, stable effusion (like those common in connective tissue diseases), the strongest echocardiographic sign of hemodynamic compromise (tamponade physiology) is inferior vena cava (IVC) plethora with minimal respiratory collapse (<50%). This indicates elevated right atrial pressure. In chronic effusions, the chambers have had time to adapt, so classic signs like right atrial collapse may be absent or late. Respiratory variation in mitral inflow (>25%) is a sensitive sign but can be seen in other conditions like COPD. Right atrial collapse is an early sign but less specific in chronic settings. Swinging heart is seen with very large effusions but not specific for tamponade. Left atrial compression is rare.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Let me analyze this question about pericardial effusion in a patient with systemic sclerosis.\n\nThe question asks about the strongest indicator to initiate specific pharmacologic therapy for the effusion. This is essentially asking about signs of hemodynamic compromise/cardiac tamponade physiology.\n\nLet me evaluate each option:\n\nA. Right atrial diastolic collapse - This is a specific sign of cardiac tamponade. The right atrium collapses during diastole when pericardial pressure exceeds right atrial pressure. This is an early and sensitive sign of tamponade physiology, indicating hemodynamic compromise.\n\nB. Respiratory variation in mitral inflow velocity >25% - This indicates pulsus paradoxus and ventricular interdependence, which is a sign of tamponade. However, the threshold is typically >25-30% for significant tamponade physiology.\n\nC. Inferior vena cava plethora with <50% collapse on sniff - This indicates elevated right atrial pressure but is nonspecific. It can be seen in many conditions (heart failure, volume overload) and alone doesn't indicate tamponade.\n\nD. Swinging heart motion - This is seen with large effusions but doesn't necessarily indicate hemodynamic compromise. It's more of a descriptive finding.\n\nE. Left atrial compression during systole - Left atrial collapse is less common and typically occurs later than right-sided collapse due to higher left-sided pressures.\n\nThe key distinction is between signs that indicate hemodynamic compromise requiring intervention versus findings that are simply descriptive of the effusion.\n\nRight atrial diastolic collapse (A) is considered one of the most specific echocardiographic signs of early tamponade physiology. It indicates that pericardial pressure is exceeding chamber filling pressures, which is a clear indication for intervention.\n\nWhile respiratory variation >25% (B) is also important, right atrial collapse is generally considered the strongest and most specific early indicator of hemodynamic compromise that would prompt therapy.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-010", "question": "A 16-year-old girl is brought to the ED after collapsing during her high school soccer game. She was pulseless and apneic but received immediate bystander CPR and was defibrillated once with ROSC after 4 minutes. Her initial ECG in the ED shows sinus rhythm with diffuse ST-segment elevation in precordial leads V1-V4 and inferior leads II, III, aVF. Bedside echocardiogram shows severe hypokinesis of the mid to apical left ventricle with hypercontractility of the basal segments. Troponin I is elevated at 15 ng/mL. Which of the following is the most critical next step in management to prevent recurrence?", "options": ["Immediate coronary angiography", "Initiation of an intravenous beta-blocker", "Insertion of a wearable cardioverter-defibrillator", "Initiation of intravenous immunoglobulin (IVIG)", "Administration of intravenous calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation and echocardiographic findings are classic for Takotsubo (stress) cardiomyopathy, which can rarely present with ventricular fibrillation arrest. The ECG can mimic STEMI. The most critical step to prevent recurrence of malignant arrhythmias in the acute phase is suppression of catecholamine-driven triggered activity with an intravenous beta-blocker. Immediate coronary angiography is often performed to rule out acute coronary syndrome, but the typical regional wall motion abnormality (apical ballooning) and clinical context make it less likely to be the immediate preventive measure for recurrence. ICD implantation is not indicated in the acute phase of a reversible cardiomyopathy. IVIG is for myocarditis. Calcium is for hyperkalemia or calcium channel blocker overdose.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n- 16-year-old female athlete\n- Sudden cardiac arrest during exercise\n- Successfully defibrillated (implies shockable rhythm - VF/VT)\n- ECG: ST elevation in V1-V4 and inferior leads\n- Echo: Apical/mid LV hypokinesis with basal hypercontractility (classic \"apical ballooning\" pattern)\n- Elevated troponin (15 ng/mL)\n\nDifferential Diagnosis:\nThe echo findings of apical hypokinesis with basal hypercontractility is the classic pattern of Takotsubo cardiomyopathy (stress cardiomyopathy/apical ballooning syndrome). However, in a young athlete with sudden cardiac arrest requiring defibrillation, we must also consider:\n- Hypertrophic cardiomyopathy (HCM)\n- Arrhythmogenic right ventricular cardiomyopathy (ARVC)\n- Long QT syndrome\n- Catecholaminergic polymorphic ventricular tachycardia (CPVT)\n- Anomalous coronary arteries\n- Myocarditis\n\nAnalysis of Options:\n\nA. Coronary angiography - Important to rule out anomalous coronary arteries (a cause of sudden death in young athletes) and coronary spasm, but not the most critical for preventing recurrence.\n\nB. IV beta-blocker - Could be helpful but not the immediate priority for preventing recurrence of sudden death.\n\nC. Wearable cardioverter-defibrillator (WCD) - This patient had a sudden cardiac arrest with a shockable rhythm. She is at high risk for recurrent ventricular arrhythmias. A WCD provides protection while the underlying cause is being investigated and treated. This is critical for preventing sudden death recurrence.\n\nD. IVIG - Used for myocarditis or Kawasaki disease, not indicated here based on presentation.\n\nE. IV calcium gluconate - Used for hypocalcemia or hyperkalemia, not relevant here.\n\nBest Answer:\nGiven that this patient survived sudden cardiac arrest from a presumed ventricular arrhythmia, the most critical step to prevent recurrence is protection with a defibrillator. A wearable cardioverter-defibrillator is appropriate as a bridge while determining the underlying etiology and whether a permanent ICD is needed.\n\nThe answer is (C)"}]